MiNK Therapeutics, Inc. (INKT) Social Stream
MINK THERAPEUTICS INC (INKT) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering INKT.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 4 | $30 | $24 | $26.666 | $1.01 | 2540.2% |
| 2022-03-21 | 4 | $30 | $10 | $22 | $1.01 | 2078.22% |
| 2022-05-11 | 5 | $30 | $7 | $21 | $1.01 | 1979.21% |
| 2022-11-06 | 5 | $30 | $7 | $17.5 | $1.01 | 1632.67% |
| 2022-11-14 | 3 | $7 | $7 | $7 | $1.01 | 593.07% |
| 2023-03-22 | 4 | $7 | $7 | $7 | $1.01 | 593.07% |
| 2023-04-19 | 4 | $7 | $3 | $5.666 | $1.01 | 460.99% |
| 2023-11-09 | 4 | $10 | $3 | $6.67 | $1.01 | 560.4% |
The Trend in the Analyst Price Target
Over the past 51 weeks, INKT's average price target has gone down $0.33.
INKT reports an average of 254.21% for its upside potential over the past 33 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-22 | 4 | 7 | 7 | 7.00 | 2.09 | 234.93% |
| 2023-04-19 | 4 | 7 | 3 | 5.00 | 2.05 | 143.9% |
| 2023-05-12 | 4 | 10 | 3 | 6.67 | 1.72 | 287.79% |
| 2023-08-11 | 4 | 10 | 3 | 6.67 | 1.83 | 264.48% |
| 2023-11-09 | 4 | 10 | 3 | 6.67 | 1.11 | 500.9% |
INKT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 4 | 0 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
INKT's average broker recommendation rating improved by 0 over the prior 52 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- INKT has a higher upside potential (average analyst target price relative to current price) than 1061.34% of all US stocks.
- In the context of all US stocks, MINK THERAPEUTICS INC's variance in analysts' estimates is lower than -528.82% of them.
- MINK THERAPEUTICS INC's number of analysts covering the stock is higher than 198.18% of Healthcare stocks.
- In the context of Healthcare stocks, MINK THERAPEUTICS INC's average analyst price target is higher than 244.46% of them.
In the Pharmaceutical Products industry, PRME, ACHV, and OCX are the three stocks most similar to MINK THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for INKT? Use POWR Ratings for clearer insight into price direction.